Core Viewpoint - Zhejiang Liansheng Chemical Co., Ltd. faced regulatory scrutiny for violations related to information disclosure and improper use of raised funds, resulting in a warning letter from the China Securities Regulatory Commission [1] Group 1: Regulatory Violations - The chairman, general manager, and non-independent directors of the company were found to have violated information disclosure regulations and failed to fulfill other responsibilities [1] - The company was discovered to have invested idle raised funds in financial products before the authorized review period and exceeded the authorized investment amount [1] Group 2: Financial Reporting Issues - The special reports on the use of raised funds for the first half of 2023, the full year of 2023, the first half of 2024, and the full year of 2024 contained inaccurate disclosures regarding the purchase of large time deposits [1] Group 3: Regulatory Actions - The regulatory authority issued a warning letter as a supervisory measure, which will be recorded in the securities and futures market integrity file [1]
联盛化学因信息披露违规等违规行为被证监会出具警示函